Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 22

Trial Status

Completed1
Other1

Role Distribution

Principal Investigator2
PI Rate100%

Activity Timeline

Clinical Trials (2)

NCT03213704Phase 2Active Not Recruiting
Larotrectinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With NTRK Fusions (A Pediatric MATCH Treatment Trial)
Advanced Malignant Solid NeoplasmRecurrent EpendymomaRecurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor+30 more
PrincipalinvestigatorStart date: 2017-08-23
NCT02470091Phase 2Completed
Denosumab in Treating Patients With Recurrent or Refractory Osteosarcoma
Metastatic OsteosarcomaRecurrent OsteosarcomaRefractory Osteosarcoma+3 more
PrincipalinvestigatorStart date: 2015-11-21

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Behnam Badie

City of Hope Medical Center

Related
6 trials

Shared therapeutic areas:

Recurrent Malignant GliomaRecurrent GliomaRefractory Glioma+1 more

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score3%

Patricia M LoRusso

Yale University Cancer Center LAO

Related
6 trials

Shared therapeutic areas:

Advanced Malignant Solid NeoplasmRefractory Malignant Solid NeoplasmRecurrent Glioma+1 more

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score3%

David Hui, MD

M.D. Anderson Cancer Center

Related
13 trials

Shared therapeutic areas:

Advanced Malignant Solid NeoplasmRecurrent Malignant Solid Neoplasm

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score2%

Anthony El-Khoueiry, MD

University of Southern California

Related
6 trials

Shared therapeutic areas:

Advanced Malignant Solid NeoplasmRefractory Malignant Solid Neoplasm

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score2%

A P Chen

National Cancer Institute LAO

Related
8 trials

Shared therapeutic areas:

Advanced Malignant Solid NeoplasmRecurrent Malignant Solid Neoplasm

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score2%

Sriram Yennu

M.D. Anderson Cancer Center

Related
12 trials

Shared therapeutic areas:

Advanced Malignant Solid NeoplasmRecurrent Malignant Solid Neoplasm

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score2%

David Maloney

Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium

Related
11 trials

Shared therapeutic areas:

Recurrent Non-Hodgkin LymphomaRefractory Non-Hodgkin Lymphoma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score2%

Edward A Neuwelt

OHSU Knight Cancer Institute

Related
6 trials

Shared therapeutic areas:

Recurrent Malignant Germ Cell TumorRecurrent Medulloblastoma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score2%

Amir A Jazaeri

M.D. Anderson Cancer Center

Related
7 trials

Shared therapeutic areas:

Recurrent OsteosarcomaRefractory Osteosarcoma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score2%

David Hui

M.D. Anderson Cancer Center

Related
9 trials

Shared therapeutic areas:

Advanced Malignant Solid NeoplasmRecurrent Malignant Solid Neoplasm

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score2%

Publications (0)

No publications found for this investigator.

Clinical Trials (2)

Showing 2 of 2 trials

NCT03213704Phase 2PrincipalInvestigator

Larotrectinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With NTRK Fusions (A Pediatric MATCH Treatment Trial)

Advanced Malignant Solid NeoplasmRecurrent EpendymomaRecurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor+30 more
Active Not Recruiting
NCT02470091Phase 2PrincipalInvestigator

Denosumab in Treating Patients With Recurrent or Refractory Osteosarcoma

Metastatic OsteosarcomaRecurrent OsteosarcomaRefractory Osteosarcoma+3 more
Completed

All 2 trials loaded